SUPN - Supernus Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$60.00
DETAILS
HIGH:
$65.00
LOW:
$55.00
MEDIAN:
$60.00
CONSENSUS:
$60.00
UPSIDE:
24.46%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue | 719.0 | 661.8 | 607.5 | 667.2 | 579.8 | 520.4 | 392.8 | 408.9 | 302.2 | 215.0 | 144.4 | 122.0 | 12.0 | 1.5 | 0.8 | 0.1 | 37.9 | 8.9 | 4.2 |
| Cost of Revenue | 74.6 | 77.9 | 83.8 | 87.2 | 75.1 | 52.5 | 16.7 | 15.4 | 15.2 | 12.0 | 8.4 | 5.8 | 1.1 | 0 | 0 | (13.4) | (8.6) | 0.0 | 0 |
| Gross Profit | 644.4 | 583.9 | 523.7 | 580.0 | 504.7 | 467.9 | 376.1 | 393.5 | 287.0 | 203.0 | 136.0 | 116.3 | 10.9 | 1.5 | 0.8 | 13.5 | 46.5 | 8.9 | 4.2 |
| Operating Expenses | |||||||||||||||||||
| R&D Expenses | 106.2 | 108.8 | 91.6 | 74.6 | 90.5 | 76.0 | 69.1 | 89.2 | 49.6 | 42.8 | 29.1 | 19.6 | 17.2 | 23.5 | 30.6 | 35.1 | 29.3 | 30.5 | 19.3 |
| SG&A Expenses | 485.6 | 335.8 | 336.4 | 377.2 | 304.8 | 200.7 | 158.4 | 159.9 | 137.9 | 106.0 | 89.2 | 72.5 | 55.6 | 20.1 | 7.9 | 5.1 | 4.6 | 4.3 | 4.0 |
| Other Expenses | 89.5 | 57.7 | 101.1 | 82.1 | 23.5 | 17.6 | 0 | 0 | 0 | (0.0) | 0.0 | 0.0 | 0.1 | 0 | 0.1 | 0.5 | 0 | 0 | 0 |
| Operating Expenses | 681.3 | 502.2 | 529.0 | 533.9 | 418.7 | 294.2 | 227.5 | 249.1 | 187.5 | 148.8 | 118.3 | 92.1 | 72.8 | 43.6 | 38.6 | 40.2 | 33.9 | 34.8 | 23.3 |
| Operating Income | |||||||||||||||||||
| Operating Income | (36.9) | 81.7 | (5.3) | 46.1 | 86.0 | 173.7 | 148.6 | 144.4 | 99.5 | 54.2 | 17.7 | 24.2 | (61.9) | (42.2) | (37.8) | (40.1) | 4.0 | (25.9) | (19.0) |
| Interest Expense | 0 | 0 | 2.4 | 7.1 | 23.4 | 23.8 | 22.7 | 18.1 | 1.6 | 5.1 | 4.8 | 5.6 | 7.8 | 3.6 | 1.9 | 0 | 0 | 8.7 | 0 |
| Interest Income | 13.3 | 16.2 | 10.5 | 21.7 | 10.6 | 18.7 | 21.6 | 13.8 | 2.6 | 1.5 | 0.7 | 0.3 | 0.3 | 0.1 | 0.0 | 0.1 | 0.1 | 1.1 | 1.8 |
| Profitability | |||||||||||||||||||
| EBITDA | 42.5 | 178.3 | 90.0 | 153.4 | 129.2 | 210.5 | 180.4 | 151.5 | 107.7 | 56.6 | 21.8 | (4.3) | (83.7) | (41.8) | (36.7) | (38.3) | 5.2 | (23.7) | (16.3) |
| EBIT | (49.0) | 97.9 | 5.2 | 67.8 | 96.6 | 192.4 | 170.2 | 144.4 | 99.5 | 54.2 | 20.8 | 24.8 | (84.4) | (42.7) | (37.6) | (39.5) | 4.1 | (24.8) | (17.3) |
| Income Before Tax | (49.0) | 97.9 | 2.8 | 60.7 | 73.2 | 168.6 | 147.5 | 140.2 | 100.6 | 50.4 | 15.0 | 19.9 | (92.3) | (46.3) | (39.5) | (39.5) | 4.1 | (33.5) | (17.3) |
| Income Tax Expense | (10.5) | 24.0 | 1.5 | 0.0 | 19.8 | 41.7 | 34.4 | 29.2 | 43.3 | (40.9) | 1.0 | 0 | 0 | 0 | (16.2) | (0.4) | 0 | 0 | 0 |
| Net Income | (38.5) | 73.9 | 1.3 | 60.7 | 53.4 | 127.0 | 113.1 | 111.0 | 57.3 | 91.2 | 14.0 | 19.9 | (92.3) | (46.3) | 56.0 | (38.5) | 0.5 | (33.5) | (17.3) |
| Per Share Data | |||||||||||||||||||
| EPS (Basic) | -0.68 | 1.34 | 0.02 | 1.13 | 1.01 | 2.41 | 2.16 | 2.13 | 1.13 | 1.84 | 0.29 | 0.47 | -2.90 | -2.65 | 3.64 | -2.78 | -0.21 | -2.42 | -1.25 |
| EPS (Diluted) | -0.68 | 1.32 | 0.02 | 1.04 | 0.98 | 2.36 | 2.10 | 2.05 | 1.08 | 1.76 | 0.28 | 0.32 | -2.90 | -2.65 | 3.64 | -2.78 | -0.21 | -2.42 | -1.25 |
| Shares Outstanding | 56.5 | 55.1 | 54.5 | 53.7 | 53.1 | 52.6 | 52.4 | 52.0 | 50.8 | 49.5 | 47.5 | 42.3 | 31.8 | 17.4 | 13.9 | 13.9 | 13.9 | 13.9 | 13.9 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||
| Cash & Cash Equivalents | 128.4 | 69.3 | 75.1 | 93.1 | 203.4 | 288.6 | 181.4 | 192.2 | 100.3 | 90.1 | 31.4 | 52.9 |
| Short-Term Investments | 180.2 | 384.3 | 179.8 | 368.2 | 136.2 | 133.9 | 165.7 | 163.8 | 39.7 | 0 | 35.1 | 7.5 |
| Net Receivables | 187.8 | 142.1 | 144.2 | 165.5 | 148.9 | 140.9 | 87.3 | 102.9 | 65.6 | 41.5 | 3.7 | 2.3 |
| Inventory | 82.4 | 54.3 | 77.4 | 91.5 | 86.0 | 48.3 | 26.6 | 25.7 | 16.3 | 16.8 | 2.3 | 6.5 |
| Other Current Assets | 65.3 | 36.1 | 16.7 | 15.8 | 0 | 0 | 0 | 8.9 | 6.5 | 3.0 | 0 | 0 |
| Total Current Assets | 644.2 | 686.1 | 493.1 | 734.2 | 601.6 | 630.4 | 472.6 | 493.5 | 228.5 | 151.4 | 72.9 | 69.5 |
| Non-Current Assets | ||||||||||||
| Property, Plant & Equipment | 10.5 | 11.5 | 13.5 | 15.2 | 17.0 | 37.8 | 17.1 | 4.1 | 5.1 | 4.3 | 1.9 | 2.0 |
| Goodwill | 124.9 | 117.0 | 117.0 | 117.0 | 117.5 | 77.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 569.5 | 521.9 | 599.9 | 702.5 | 784.7 | 364.3 | 24.8 | 31.4 | 36.0 | 16.5 | 1.4 | 1.6 |
| Long-Term Investments | 0 | 0 | 16.6 | 93.9 | 119.2 | 350.4 | 591.8 | 418.8 | 133.6 | 75.4 | 0 | 0 |
| Other Non-Current Assets | 65.2 | 31.5 | 37.5 | 39.8 | 49.2 | 43.2 | 21.9 | 0.4 | 0.4 | 20.2 | 3.8 | 4.1 |
| Total Non-Current Assets | 808.5 | 682.0 | 784.6 | 968.4 | 1,087.6 | 873.7 | 687.6 | 484.3 | 196.0 | 158.2 | 7.0 | 7.7 |
| Total Assets | 1,452.6 | 1,368.1 | 1,277.7 | 1,702.5 | 1,689.2 | 1,504.1 | 1,160.3 | 977.8 | 424.5 | 309.6 | 79.9 | 77.1 |
| Current Liabilities | ||||||||||||
| Account Payables | 2.7 | 4.6 | 2.0 | 10.5 | 9.3 | 6.1 | 10.1 | 3.2 | 6.8 | 8.1 | 6.2 | 4.5 |
| Short-Term Debt | 0 | 0 | 0 | 402.0 | 0 | 0 | 0 | 2.2 | 4.3 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (2.2) | 0.3 | 0.2 | 0 | 0 |
| Other Current Liabilities | 98.7 | 68.6 | 77.1 | 54.9 | 93.0 | 56.0 | 14.5 | 23.0 | 17.0 | 63.3 | 1.3 | 2.5 |
| Total Current Liabilities | 338.2 | 292.4 | 290.2 | 688.0 | 315.4 | 245.1 | 160.6 | 161.4 | 123 | 80.7 | 10.0 | 8.3 |
| Non-Current Liabilities | ||||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 379.3 | 361.8 | 345.2 | 329.5 | 22.3 | 4.2 | 75 | 75 |
| Deferred Tax Liabilities | 0 | 5.0 | 25.0 | 49.8 | 85.4 | 35.2 | 0 | 31.5 | 15.0 | 0.1 | 0 | (75) |
| Other Non-Current Liabilities | 22.4 | 7.6 | 7.8 | 42.5 | 52.0 | 68.4 | 28.7 | 34.0 | 10.6 | 31.4 | 1.0 | 0.2 |
| Total Non-Current Liabilities | 52.8 | 39.9 | 66.0 | 128.3 | 557.9 | 514.1 | 404.3 | 363.4 | 34.0 | 37.1 | 76.0 | 75.6 |
| Total Liabilities | 390.9 | 332.3 | 356.2 | 816.3 | 873.3 | 759.2 | 564.9 | 524.8 | 157.0 | 117.8 | 86.1 | 83.9 |
| Stockholders' Equity | ||||||||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Retained Earnings | 517.9 | 556.4 | 482.6 | 481.2 | 379.9 | 326.5 | 199.5 | 86.5 | (26.8) | (84.3) | (55.3) | (55.8) |
| Accumulated Other Comprehensive Income | (0.0) | (0.2) | (0.6) | (3.2) | 1.5 | 9.0 | 7.4 | (3.2) | (0.7) | (0.1) | 0.0 | (2.1) |
| Total Stockholders' Equity | 1,061.7 | 1,035.7 | 921.5 | 886.2 | 815.9 | 744.9 | 595.4 | 453.0 | 267.5 | 191.8 | (6.2) | (6.7) |
| Total Liabilities & Equity | 1,452.6 | 1,368.1 | 1,277.7 | 1,702.5 | 1,689.2 | 1,504.1 | 1,160.3 | 977.8 | 424.5 | 309.6 | 79.9 | 77.1 |
| Debt Metrics | ||||||||||||
| Total Debt | 41.0 | 34.3 | 41.5 | 444.8 | 427.0 | 414.3 | 378.4 | 329.5 | 26.5 | 4.2 | 75 | 75 |
| Net Debt | (87.5) | (35.1) | (33.5) | 351.6 | 223.6 | 125.7 | 197.1 | 137.2 | (73.8) | (86.0) | 43.6 | 22.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (38.5) | 73.9 | 1.3 | 60.7 | 53.4 | 127.0 | 113.1 | 111.0 | 57.3 | 91.2 |
| Depreciation & Amortization | 90.0 | 80.4 | 84.9 | 85.5 | 32.6 | 18.1 | 6.7 | 7.1 | 8.1 | 2.4 |
| Stock-Based Compensation | 33.1 | 27.8 | 26.8 | 17.6 | 17.9 | 16.6 | 14.8 | 11.3 | 8.4 | 5.9 |
| Change in Working Capital | (75.2) | (2.1) | (9.1) | (24.2) | 3.6 | (36.5) | 0.6 | (4.7) | 23.7 | 8.4 |
| Other Non-Cash Items | 32.7 | 12.1 | 33.0 | 3.6 | 24.6 | 12.7 | 13.8 | 8.5 | (4.1) | 0.6 |
| Operating Cash Flow | 47.3 | 172.0 | 111.1 | 116.8 | 127.1 | 138.4 | 143.1 | 129.0 | 114.6 | 66.8 |
| Investing Activities | ||||||||||
| Capital Expenditure | (1.3) | (0.7) | (0.6) | (0.4) | (2.0) | (3.4) | (2.7) | (0.8) | (2.0) | (1.6) |
| Acquisitions | (293.1) | 0 | 0 | (0.0) | (311.7) | (313.5) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (475.9) | (688.0) | (101.6) | (407.0) | (311.6) | (95.9) | (409.7) | (491.7) | (101.9) | (47.4) |
| Sales/Maturities of Investments | 774.9 | 498.9 | 370.9 | 190.7 | 530.5 | 378.4 | 253.2 | 79.8 | 28.7 | 31.8 |
| Other Investing Activities | (0.4) | 0.0 | 0 | 0.0 | 12.9 | (0.2) | 1.3 | (0.8) | (11.2) | (18.8) |
| Investing Cash Flow | 4.1 | (189.9) | 268.7 | (216.7) | (81.9) | (34.7) | (157.9) | (413.5) | (86.4) | (36.0) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | (402.5) | 0 | (137.5) | (0.8) | 0 | 309.6 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (28.5) | (2.7) | (2.0) | (22.9) | 0 | 0 | 0 | 55.3 | 0 | 0 |
| Financing Cash Flow | 9.1 | 12.2 | (397.9) | (10.5) | (130.4) | 3.6 | 3.9 | 376.4 | 5.7 | 2.1 |
| Cash Position | ||||||||||
| Net Change in Cash | 60.6 | (5.7) | (18.1) | (110.3) | (85.2) | 107.3 | (10.9) | 91.9 | 33.9 | 32.9 |
| Cash at Beginning | 69.3 | 75.1 | 93.1 | 203.4 | 288.6 | 181.4 | 192.2 | 100.3 | 66.4 | 33.5 |
| Cash at End | 129.9 | 69.3 | 75.1 | 93.1 | 203.4 | 288.6 | 181.4 | 192.2 | 100.3 | 66.4 |
| Free Cash Flow | 46.0 | 171.2 | 110.5 | 116.4 | 125.1 | 134.9 | 140.4 | 128.1 | 112.6 | 65.2 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||||
| Revenue | 719.0 | 661.8 | 607.5 | 667.2 | 579.8 | 520.4 | 392.8 | 408.9 | 302.2 | 215.0 | 144.4 | 122.0 | 12.0 | 1.5 | 0.8 | 0.1 | 37.9 | 8.9 | 4.2 |
| Gross Profit | 644.4 | 583.9 | 523.7 | 580.0 | 504.7 | 467.9 | 376.1 | 393.5 | 287.0 | 203.0 | 136.0 | 116.3 | 10.9 | 1.5 | 0.8 | 13.5 | 46.5 | 8.9 | 4.2 |
| Operating Income | (36.9) | 81.7 | (5.3) | 46.1 | 86.0 | 173.7 | 148.6 | 144.4 | 99.5 | 54.2 | 17.7 | 24.2 | (61.9) | (42.2) | (37.8) | (40.1) | 4.0 | (25.9) | (19.0) |
| Net Income | (38.5) | 73.9 | 1.3 | 60.7 | 53.4 | 127.0 | 113.1 | 111.0 | 57.3 | 91.2 | 14.0 | 19.9 | (92.3) | (46.3) | 56.0 | (38.5) | 0.5 | (33.5) | (17.3) |
| EPS (Diluted) | -0.68 | 1.32 | 0.02 | 1.04 | 0.98 | 2.36 | 2.10 | 2.05 | 1.08 | 1.76 | 0.28 | 0.32 | -2.90 | -2.65 | 3.64 | -2.78 | -0.21 | -2.42 | -1.25 |
| Balance Sheet | |||||||||||||||||||
| Cash & Equivalents | 128.4 | 69.3 | 75.1 | 93.1 | 203.4 | 288.6 | 181.4 | 192.2 | 100.3 | 90.1 | 31.4 | 52.9 | |||||||
| Total Assets | 1,452.6 | 1,368.1 | 1,277.7 | 1,702.5 | 1,689.2 | 1,504.1 | 1,160.3 | 977.8 | 424.5 | 309.6 | 79.9 | 77.1 | |||||||
| Total Debt | 41.0 | 34.3 | 41.5 | 444.8 | 427.0 | 414.3 | 378.4 | 329.5 | 26.5 | 4.2 | 75 | 75 | |||||||
| Stockholders' Equity | 1,061.7 | 1,035.7 | 921.5 | 886.2 | 815.9 | 744.9 | 595.4 | 453.0 | 267.5 | 191.8 | (6.2) | (6.7) | |||||||
| Cash Flow | |||||||||||||||||||
| Operating Cash Flow | 47.3 | 172.0 | 111.1 | 116.8 | 127.1 | 138.4 | 143.1 | 129.0 | 114.6 | 66.8 | |||||||||
| Capital Expenditure | (1.3) | (0.7) | (0.6) | (0.4) | (2.0) | (3.4) | (2.7) | (0.8) | (2.0) | (1.6) | |||||||||
| Free Cash Flow | 46.0 | 171.2 | 110.5 | 116.4 | 125.1 | 134.9 | 140.4 | 128.1 | 112.6 | 65.2 | |||||||||